THOMAS P MILLER, MD
Osteopathic Medicine at Campbell Ave, Tucson, AZ
License number
Arizona 12126
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1515 N Campbell Ave, Tucson, AZ 85724
Phone
(520) 626-2816
(520) 626-3754 (Fax)
(520) 874-7400
(520) 874-3425 (Fax)
(520) 626-3754 (Fax)
(520) 874-7400
(520) 874-3425 (Fax)
Organization information
See more information about THOMAS P MILLER at bizstanding.comArizona Cancer Ctr-Umc North - Joanne Jeter MD
3838 N Campbell Ave, Tucson, AZ 85719
Industry:
Offices of Physicians, Except Mental Health
Doing business as:
Arizona Cancer Ctr-Umc North - Linda L Garland MD<br>Arizona Cancer Ctr-Umc North - James Warneke MD<br>Arizona Cancer Ctr-Umc North - Michele Ley MD<br>Arizona Cancer Ctr-Umc North - David S Alberts MD<br>Arizona Cancer Ctr-Umc North - Robert Livingston MD<br>Arizona Cancer Ctr-Umc North - Clara Curiel MD<br>Arizona Cancer Ctr-Umc North - Frederick R Ahmann MD<br>Arizona Cancer Ctr-Umc North - Maria C Bishop MD<br>Arizona Cancer Ctr-Umc North - Andrew Yeager MD<br>Arizona Cancer Ctr-Umc North - Thomas P Miller MD<br>Arizona Cancer Ctr<br>Arizona Cancer Center Umc North
Site:
Phone:
(520) 694-2873 (Phone)
SIC:
8011 - Offices and Clinics of Doctors of Medicine
Company size:
8
Professional information
See more information about THOMAS P MILLER at trustoria.com
Dr. Thomas P Miller, Tucson AZ - MD (Doctor of Medicine)
Dr. Thomas P Miller, Tucson AZ - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
3838 N Campbell Ave, Tucson 85719
(520) 694-2873 (Phone)
(520) 694-2873 (Phone)
Certifications:
Internal Medicine, 1977, Medical Oncology, 1981
Awards:
Healthgrades Honor Roll
Languages:
English, Spanish
Hospitals:
3838 N Campbell Ave, Tucson 85719
The University of Arizona Medical Center
1501 North Campbell Ave, Tucson 85724
The University of Arizona Medical Center
1501 North Campbell Ave, Tucson 85724
Education:
Medical School
University Of Illinois College Of Medicine Chicago
Graduated: 1972
University Of Illinois
Graduated: 1973
Graduated: 1977
University Ariz University Med Center
Graduated: 1980
University Of Illinois College Of Medicine Chicago
Graduated: 1972
University Of Illinois
Graduated: 1973
Graduated: 1977
University Ariz University Med Center
Graduated: 1980
Thomas Patrick Miller, Tucson AZ
Thomas Patrick Miller, Tucson AZ
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology, Allergy & Immunology, Anesthesiology, Pain Medicine
Work:
Arizona Cancer Ctr
3838 N Campbell Ave, Tucson, AZ 85719 Arizona Cancer Ctr
1515 N Campbell Ave, Tucson, AZ 85724 Specialists In Pain Management
2339 Mccallie Ave, Chattanooga, TN 37404 University Medical Center - Tucson
1501 N Campbell Ave, Tucson, AZ 85724 University of Arizona Health Network
1891 W Orange Grove Rd, Tucson, AZ 85704 Southern Pain Specialists LLC
705 Cook Dr, Athens, TN 37303 Allergy Associates of Western Michigan
3185 Macatawa Dr SW, Grandville, MI 49418 Allergy Associates of Western Mich (2)
360 E Beltline Ave NE, Grand Rapids, MI 49506
3838 N Campbell Ave, Tucson, AZ 85719 Arizona Cancer Ctr
1515 N Campbell Ave, Tucson, AZ 85724 Specialists In Pain Management
2339 Mccallie Ave, Chattanooga, TN 37404 University Medical Center - Tucson
1501 N Campbell Ave, Tucson, AZ 85724 University of Arizona Health Network
1891 W Orange Grove Rd, Tucson, AZ 85704 Southern Pain Specialists LLC
705 Cook Dr, Athens, TN 37303 Allergy Associates of Western Michigan
3185 Macatawa Dr SW, Grandville, MI 49418 Allergy Associates of Western Mich (2)
360 E Beltline Ave NE, Grand Rapids, MI 49506
Education:
Wayne State University
Thomas P Miller, Tucson AZ
Thomas P Miller, Tucson AZ
Specialties:
Oncologist
Address:
1515 N Campbell Ave, Tucson, AZ 85724
3838 N Campbell Ave, Tucson, AZ 85719
3838 N Campbell Ave, Tucson, AZ 85719
Education:
University of Illinois, College of Medicine - Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
US Patent:
8131475, Mar 6, 2012
Filed:
Jul 25, 2006
Appl. No.:
11/493387
Inventors:
Louis M. Staudt - Silver Spring MD, US
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhom NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zettl - Würzburg, DE
German Ott - Würzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaløy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhom NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zettl - Würzburg, DE
German Ott - Würzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaløy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
Assignee:
The United States of America as represented by the Secretary, Department of Health and Human Services - Washington DC
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents of Behalf of the University of Arizona - Tucson AZ
Universitat de Barcelona - Barcelona
Fundacio Clinic - Barcelona
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wuerzburg
British Columbia Cancer Agency Branch - Vancouver
Oslo University Hospital HF - Oslo
Queen Mary and Westfield College, University of London - London
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents of Behalf of the University of Arizona - Tucson AZ
Universitat de Barcelona - Barcelona
Fundacio Clinic - Barcelona
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wuerzburg
British Columbia Cancer Agency Branch - Vancouver
Oslo University Hospital HF - Oslo
Queen Mary and Westfield College, University of London - London
International Classification:
G01N 33/48, C12Q 1/68, G06G 7/58
US Classification:
702 19, 435 6, 702 20, 703 11
Abstract:
Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
Methods For Identifying, Diagnosing, And Predicting Survival Of Lymphomas
US Patent:
2012022, Sep 6, 2012
Filed:
Mar 1, 2012
Appl. No.:
13/409416
Inventors:
Louis M. Staudt - Silver Spring MD, US
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhorn NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M. Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zetti - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
George Wright - Rockville MD, US
Sandeep Dave - Washington DC, US
Bruce Tan - Baltimore MD, US
John I. Powell - Ijamsville MD, US
Wyndham Wilson - Washington DC, US
Elaine Jaffe - Great Falls VA, US
Wing C. Chan - Omaha NE, US
Timothy C. Greiner - Council Bluffs IA, US
Dennis Weisenburger - Elkhorn NE, US
James Armitage - Omaha NE, US
Kai Fu - Omaha NE, US
Richard I. Fisher - Pittsford NY, US
Lisa Rimsza - Tucson AZ, US
Thomas Miller - Tucson AZ, US
Thomas Grogan - Tucson AZ, US
Elias Campo - Barcelona, ES
Silvia M. Bea - Sabadell, ES
Itziar Salaverria - Barcelona, ES
Armando Lopez-Guillermo - Barcelona, ES
Emili Montserrat - Barcelona, ES
Victor Moreno - Barcelona, ES
Andreas Zetti - Wurzburg, DE
German Ott - Wurzburg, DE
Hans-Konrad Muller-Hermelink - Wuerzburg, DE
Andreas Rosenwald - Wuerzburg, DE
Julie Vose - Omaha NE, US
Randy Gascoyne - North Vancouver, CA
Joseph Connors - Vancouver, CA
Erlend Smeland - Oslo, NO
Stein Kvaloy - Oslo, NO
Harald Holte - Oslo, NO
Jan Delabie - Oslo, NO
T. Andrew Lister - London, GB
Assignee:
The United States of America, as Represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents on Behalf of the University of Arizona - Tucson AZ
Universitat De Barcelona - Barcelona
Queen Mary and Westfield College, University of London - London
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wrzburg
British Columbia Cancer Agency Branch - Vancover
Oslo University Hospital HE - Oslo
Fundacio Clinic - Barcelona
Board of Regents of the University of Nebraska - Lincoln NE
University of Rochester - Rochester NY
Arizona Board of Regents on Behalf of the University of Arizona - Tucson AZ
Universitat De Barcelona - Barcelona
Queen Mary and Westfield College, University of London - London
Hospital Clinic - Barcelona
Julius-Maximilians-University of Wuerzburg - Wrzburg
British Columbia Cancer Agency Branch - Vancover
Oslo University Hospital HE - Oslo
Fundacio Clinic - Barcelona
International Classification:
C40B 30/04
US Classification:
506 9
Abstract:
Gene expression data provides a basis for more accurate identification and diagnosis of lymphoproliferative disorders. In addition, gene expression data can be used to develop more accurate predictors of survival. The present invention discloses methods for identifying, diagnosing, and predicting survival in a lymphoma or lymphoproliferative disorder on the basis of gene expression patterns. The invention discloses a novel microarray, the Lymph Dx microarray, for obtaining gene expression data from a lymphoma sample. The invention also discloses a variety of methods for utilizing lymphoma gene expression data to determine the identity of a particular lymphoma and to predict survival in a subject diagnosed with a particular lymphoma. This information will be useful in developing the therapeutic approach to be used with a particular subject.